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S6 AbstractsOur results provide a quantitative approach for measuring smoke-related
changes in the lung.
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Imbalance between proteases and antiproteases is believed to play an
important role in lung tissue destruction leading to COPD and pulmonary
emphysema. We investigated this by studying the association of several
genes involved in protease-antiprotease balance to different emphysema
subtypes and lung function among Finnish construction workers.
Six single nucleotide polymorphisms (SNPs) from five genes (MMP1, MMP9,
MMP12, TIMP2, and SERPINE2) were analyzed from 951 clinically and radiolog-
ically characterized construction workers. The genotype and haplotype data
was compared to different emphysematous signs confirmed with HRCT (centri-
lobular, paraceptal, panlobular, and bullae), forced vital capacity (FVC),
forced expiratory volume in one second (FEV1), maximal expiratory flow at
50% of FVC (MEF50), total lung capacity (TLC), single breath diffusing capacity
for carbon monoxide (DLCO), and specific diffusing capacity (DLCO/VA).
The SERPINE2 rs729631 variant allele and a haplotype consisting of variant
alleles of rs729631 and rs840088 were found to predispose to pathological
panlobular emphysema (OR 4.37 95% CI 1.61-11.86) [1]. In contrast, the
MMP9 rs3918242 variant allele was found to protect from pathological cen-
trilobular emphysema (OR 0.53, 95% CI 0.30-0.90). The TIMP2 rs2277698
SNP variant allele, in turn, was found to predispose to pathological paracep-
tal emphysema (OR 1.94, 95% CI 1.14-3.30) and decreased MEF50 (pZ0.012).
Our findings strengthen the hypothesis of the importance of protease-anti-
protease balance in development of COPD and emphysema. They also shed light
on the etiology of different emphysema subtypes by suggesting associations
between SERPINE2and panlobular emphysema,MMP9and centrilobular emphy-
sema, and TIMP2, paraceptal emphysema and airflow obstruction.
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Treatment and prevention of co-morbidities in patients with chronic
obstructive pulmonary disease (COPD) has great potential to improve the
overall prognosis of COPD patients.
We assessed the extent of myocardial infarction and other co-morbidities in
individuals with COPD in the general population.
We used individual participant data for the entire Danish population from 1980
through 2006, comprising 140 million person-years of follow-up. We detected
ever-diagnosed COPD (nZ313,958) and incident cases of myocardial infarction
(nZ422,344), lung cancer (nZ115,296), hip fracture (nZ53,756), depression
(nZ91,868), and diabetes mellitus (nZ290,942). Multivariate adjusted hazard
ratios for life-time association with ever-diagnosed COPD were 1.26 (95% CI
1.25-1.27) for myocardial infarction, 2.05 (2.03-2.08) for lung cancer, 2.12
(2.07-2.17) for hip fracture, 1.74 (1.70-1.77) for depression, and 1.21 (1.20-
1.23) for diabetes mellitus, compared with controls. Before the first hospital-
isation with COPD, multivariate adjusted odds ratios were 1.47 (1.44-1.49) for
myocardial infarction, 3.68 (3.52-3.84) for lung cancer, 1.16 (1.13-1.18) for hipfracture, 1.88 (1.80-1.96) for depression, and 1.16 (1.13-1.18) for diabetes
mellitus, compared with matched controls. Corresponding values after a COPD
hospitalisation were 0.74 (0.73-0.76), 1.48 (1.45-1.51), 1.23 (1.20-1.27), 1.21
(1.18-1.24), and 0.83 (0.81-0.85), respectively.
COPD was associated with higher rates of myocardial infarction, lung cancer,
diabetes, hip fracture, anddepression, but the strengthof theseassociationswere
modified after a first admission for COPD. These associations may be related to
commongeneticand/orunsafe lifestyle/environmental risk factors,andtherefore
are those factors likely to have an adverse health impact rather than COPD per se.
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Background: Pulse oximetry has become an important tool in evaluating,
and monitoring pulmonary diseases. There is limited knowledge on distribu-
tion of SpO2 values in a general population.
Aims and objectives: We wanted to determine independent predictors of
low pulse oximetry values in a screened population.
Methods: A cross-sectional population based survey was performed in the
city of Tromsø, Norway, in 2007-2008. Valid spirometry and pulse oximetry
(SpO2) were performed in 6320 participants aged 38-87 years (57 % women).
The examinations also included questionnaires and readings for hemoglobin,
C-reactive protein (CRP), pulse, weight and height. We considered resting
oxygen saturation  95 as an abnormal value. Predictors of SpO2  95%
with a statistical significance of p<0.25 were entered into a logistic regres-
sion model. In the final model we included predictors with p0.05.
Results:We found SpO2  95% in 400 participants (6.3 %) and SpO2  92 in 30
(0.5 %). The strongest predictors in the logistic regression (p<0.001) were
increased BMI, reduced FEV1% predicted, and increased age, hemoglobin
and CRP. Other significant predictors were current smoking (pZ0.001) and
former smoking (pZ0.037). The following variables did not reach statistical
significance; pulse, self-reported asthma, COPD, cardiovascular disease,
atrial fibrillation, diabetes and hypertension, neither did pack-years, dys-
pnea, cough, and recent airway infection. Sex was an insignificant factor
in the final model.
Conclusion: Independent predictors of SpO2  95% in this population based
survey were BMI ([), FEV1% predicted (Y), age ([), hemoglobin ([), CRP ([),
and history of smoking ([).
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Within-breath change in reactance at 5 Hz (DX5) during tidal breathing
reliably detects EFL in patients with COPD1. We used this method to deter-
mine the presence of EFL in 268 stable COPD patients from the Bergen
cohort of the Eclipse study. Our aim was to examine the association between
EFL and history of exacerbations.
The Eclipse study was a multi-centre, three-year observational, non-
interventional, case-control study with a total of 8 visits. For further
characterization, see Agusti et al2. We compared the self-reported exacer-
bation history 12 months before visit 1 in COPD patients without EFL
compared with those who experienced EFL during the duration of the study.
A COPD patient with 2 or more exacerbations was defined as a frequent
exacerbator.
FOT measurements were performed using a Masterscreen IOS. Within-breath
reactance, DX5 was estimated as mean inspiratory X5 e mean expiratory X5
over a period of 30s, and EFL defined when the mean of 3 such
measurements exceeded 0.28kPa/L/s, the threshold proposed by Dellaca
et al.1
Abstracts S7We found that despite having similar levels of spirometric impairment COPD
patients with an EFL75% of the visits had a significantly worse exacerbation
history and a much higher percentage of frequent exacerbators than those
without EFL. In GOLD stage 2 those with frequent flow limitation had a
considerably higher exacerbation history while there was little difference
between the non-EFL and those with EFL<75% of the visits. The presence of
EFL at rest may be a useful way to identify patients at greater risk of these
events.
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Introduction: The Clinical COPD Questionnaire (CCQ) measures health status
and can be used to assess health-related quality of life (HRQL). We investi-
gated whether CCQ is also associated with mortality.
Methods: Some 1111 Swedish primary and secondary care COPD patients
were randomly selected. Information from questionnaires and medical re-
cord review were obtained in 970 patients. The Swedish Board of Health
and Welfare provided mortality data. Cox regression estimated survival
with adjustment for age, sex, heart disease, and lung function (for a subset
with spirometry data, nZ530). Age and sex-standardized mortality ratios
(SMR) were calculated.
Results:Overfive years, 220patients (22.7%) died.Mortality riskwashigher for
mean CCQ3 (37.8% died) comparedwithmean CCQ<1 (11.4%); producing an
adjusted HR (and 95% CI) of 3.13 (1.98 to 4.95). After further adjustment for
FEV1%pred, the association remained (HR 2.94 (1.42 to 6.10)). The mortality
risk was higher than in the general population (SMR (and 95% CI) 1.87 (1.18
to 2.80)) with CCQ <1, increasing to 6.05 (4.94 to 7.44) with CCQ 3).
Conclusion: CCQ is predictive of mortality in COPD patients. As HRQL and
mortality are both important clinical endpoints, CCQ could be used to target
interventions.
